Banned in EU

Rh-Oligopeptide-1

A cosmetic ingredient used as skin conditioning in skincare, haircare, and personal-care products sold in the European Union.

What is it?

rh-Oligopeptide-1 is a single chain recombinant human peptide, produced by fermentation in E. coli or Pichia pastoris and contains 53 amino acids. The starting gene is directly isolated from a human cell which codes for Epidermal Growth Factor, and codes for a total of 1207 amino acids which may contain disulfide bonds and/or sugar. The protein consists of the proper sequence of standard amino acids. EGF; Epidermal Growth Factor

What does it do?

Rh-Oligopeptide-1 is listed in the EU cosmetic ingredient inventory with the following declared functions:

EU regulatory status

This ingredient is banned in the European Union.

Rh-Oligopeptide-1 is listed under Annex II of EU Cosmetics Regulation 1223/2009 (entry 416), making it prohibited in cosmetic products placed on the EU market.

Frequently asked questions

What is Rh-Oligopeptide-1?

Rh-Oligopeptide-1 is a cosmetic ingredient catalogued in the EU CosIng database. rh-Oligopeptide-1 is a single chain recombinant human peptide, produced by fermentation in E. coli or Pichia pastoris and contains 53 amino acids. The starting gene is directly isolated from a human cell which codes for Epidermal Growth Factor, and codes for a total of 1207 amino acids which may contain disulfide bonds and/or sugar. The protein consists of the proper sequence of standard amino acids. EGF; Epidermal Growth Factor

Is Rh-Oligopeptide-1 allowed in cosmetics in the EU?

No. Rh-Oligopeptide-1 is banned for use in cosmetic products in the EU under Annex II of Regulation 1223/2009.

What does Rh-Oligopeptide-1 do in cosmetic products?

Rh-Oligopeptide-1 is declared in the EU cosmetic ingredient inventory with these functions: skin conditioning.

What is the CAS number of Rh-Oligopeptide-1?

The CAS (Chemical Abstracts Service) number for Rh-Oligopeptide-1 is -.

Related ingredients

Source: EU CosIng database (European Commission). This page is derived from public-sector information published by the European Commission. · Last updated: 04/03/2011